"Kidney Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancers of the KIDNEY.
| Descriptor ID |
D007680
|
| MeSH Number(s) |
C04.588.945.947.535 C12.758.820.750 C12.777.419.473 C13.351.937.820.535 C13.351.968.419.473
|
| Concept/Terms |
Kidney Neoplasms- Kidney Neoplasms
- Kidney Neoplasm
- Neoplasm, Kidney
- Renal Neoplasms
- Neoplasm, Renal
- Neoplasms, Renal
- Renal Neoplasm
- Neoplasms, Kidney
Cancer of Kidney- Cancer of Kidney
- Kidney Cancers
- Renal Cancer
- Cancer, Renal
- Cancers, Renal
- Renal Cancers
- Cancer of the Kidney
- Kidney Cancer
- Cancer, Kidney
- Cancers, Kidney
|
Below are MeSH descriptors whose meaning is more general than "Kidney Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Kidney Neoplasms".
This graph shows the total number of publications written about "Kidney Neoplasms" by people in this website by year, and whether "Kidney Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 18 | 1 | 19 |
| 1995 | 17 | 1 | 18 |
| 1996 | 19 | 3 | 22 |
| 1997 | 23 | 3 | 26 |
| 1998 | 18 | 3 | 21 |
| 1999 | 20 | 3 | 23 |
| 2000 | 13 | 5 | 18 |
| 2001 | 20 | 5 | 25 |
| 2002 | 28 | 7 | 35 |
| 2003 | 35 | 6 | 41 |
| 2004 | 25 | 7 | 32 |
| 2005 | 35 | 5 | 40 |
| 2006 | 40 | 2 | 42 |
| 2007 | 55 | 6 | 61 |
| 2008 | 65 | 8 | 73 |
| 2009 | 57 | 7 | 64 |
| 2010 | 69 | 7 | 76 |
| 2011 | 68 | 3 | 71 |
| 2012 | 63 | 5 | 68 |
| 2013 | 60 | 6 | 66 |
| 2014 | 70 | 8 | 78 |
| 2015 | 74 | 1 | 75 |
| 2016 | 70 | 6 | 76 |
| 2017 | 75 | 3 | 78 |
| 2018 | 50 | 4 | 54 |
| 2019 | 48 | 2 | 50 |
| 2020 | 59 | 4 | 63 |
| 2021 | 59 | 4 | 63 |
| 2022 | 42 | 0 | 42 |
| 2023 | 64 | 2 | 66 |
| 2024 | 35 | 2 | 37 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kidney Neoplasms" by people in Profiles.
-
Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone. Cancer Res Commun. 2024 Oct 01; 4(10):2621-2637.
-
Vascular heterogeneity of tight junction Claudins guides organotropic metastasis. Nat Cancer. 2024 Sep; 5(9):1371-1389.
-
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma. J Clin Oncol. 2024 Nov 20; 42(33):3911-3916.
-
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer. Cancer Res Commun. 2024 Sep 01; 4(9):2444-2453.
-
Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity. Int Immunopharmacol. 2024 Dec 05; 142(Pt A):113004.
-
Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case series. RMD Open. 2024 Aug 30; 10(3).
-
Mitochondrial complex I promotes kidney cancer metastasis. Nature. 2024 Sep; 633(8031):923-931.
-
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial. Ann Oncol. 2024 Nov; 35(11):1026-1038.
-
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024 Aug 01; 7(8):e2425288.
-
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. J Immunother Cancer. 2024 Jul 25; 12(7).